Fig. 3
From: Epigenetic targets of Janus kinase inhibitors are linked to genetic risks of rheumatoid arthritis
Inflammatory mediators targeted by JAKis and the TNFi. Temporal transcriptomic changes of inflammatory mediators in modules 11–15 are classified in Fig. 2b. Expression levels were Z normalized for each gene and the median value of the scores in each treatment condition is shown. ADA adalimumab, BARI baricitinib, M module, NS non-stimulated, NT non-treated, TOFA tofacitinib, UPA upadacitinib